abrdn Healthcare Investors (NYSE:HQH) is a closed-end management investment company that seeks long-term capital appreciation and current income by investing primarily in equity securities of companies operating in the healthcare sector. The fund’s portfolio generally comprises a diversified mix of domestic and international healthcare issuers, spanning pharmaceuticals, biotechnology, medical devices, healthcare services, and related industries.
The fund employs a fundamental, research-driven approach to select investments, focusing on companies with strong balance sheets, innovative product pipelines and the potential for sustainable revenue growth. Portfolio managers analyze industry trends, regulatory environments and competitive positioning to identify both established market leaders and emerging names that can benefit from scientific advancements or demographic shifts, such as aging populations and increased global healthcare spending.
Launched in 1980, abrdn Healthcare Investors is managed by abrdn, a global asset management firm with a long track record in sector-focused investing. The fund trades on the New York Stock Exchange under the ticker symbol HQH, providing investors with liquid access to a professionally managed portfolio of healthcare equities. While the fund is headquartered in the United States, its holdings often include companies across developed markets in North America, Europe and Asia, reflecting healthcare’s global nature.
AI Generated. May Contain Errors.
